New omicron sublineages surge, but Pfizer-BioNTech bivalent booster retains effectiveness Post author: Post published:October 30, 2023 Post category:uncategorized The efficacy of the bivalent Pfizer-BioNTech COVID-19 messenger ribonucleic acid (mRNA) vaccine BNT162b2 BA.4/5. You Might Also Like Historic DNA analysis identifies Down and Edwards syndromes in ancient humans February 20, 2024 Disruptions in liver and brain clocks contribute to unhealthy eating patterns November 7, 2024 TRiC mutations found to cause developmental brain malformations in children November 27, 2024